BE787901A - Vaccin antivariolique - Google Patents

Vaccin antivariolique

Info

Publication number
BE787901A
BE787901A BE787901A BE787901A BE787901A BE 787901 A BE787901 A BE 787901A BE 787901 A BE787901 A BE 787901A BE 787901 A BE787901 A BE 787901A BE 787901 A BE787901 A BE 787901A
Authority
BE
Belgium
Prior art keywords
antivariolic
vaccine
antivariolic vaccine
Prior art date
Application number
BE787901A
Other languages
English (en)
Inventor
A H Stickl
Original Assignee
Freistaat Bayern Represente Pa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19712145477 external-priority patent/DE2145477C3/de
Application filed by Freistaat Bayern Represente Pa filed Critical Freistaat Bayern Represente Pa
Publication of BE787901A publication Critical patent/BE787901A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A61K39/285—Vaccinia virus or variola virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BE787901A 1971-09-11 1972-08-23 Vaccin antivariolique BE787901A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19712145477 DE2145477C3 (de) 1971-09-11 Impfstoff für die intracutane Pockenschutzimpfung

Publications (1)

Publication Number Publication Date
BE787901A true BE787901A (fr) 1972-12-18

Family

ID=5819271

Family Applications (1)

Application Number Title Priority Date Filing Date
BE787901A BE787901A (fr) 1971-09-11 1972-08-23 Vaccin antivariolique

Country Status (5)

Country Link
AT (1) AT320149B (fr)
BE (1) BE787901A (fr)
CH (1) CH568392A5 (fr)
DK (1) DK137392C (fr)
ES (1) ES406590A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2714665A1 (de) * 1977-04-01 1978-10-05 Mayr Anton Praeparat zur behandlung von herpes zoster und anderen herpes-infektionen, sowie verfahren zu seiner herstellung
JPS60202827A (ja) * 1984-03-28 1985-10-14 Chibaken 弱毒痘そうワクチン株
CA1341245C (fr) * 1988-01-12 2001-06-05 F. Hoffmann-La Roche Ag Virus recombinant de la vaccine derive du virus modifie ankara
UA68327C2 (en) 1995-07-04 2004-08-16 Gsf Forschungszentrum Fur Unwe A recombinant mva virus, an isolated eukaryotic cell, infected with recombinant mva virus, a method for production in vitro of polypeptides with use of said cell, a method for production in vitro of virus parts (variants), vaccine containing the recombinant mva virus, a method for immunization of animals
WO2004015118A1 (fr) 2002-08-07 2004-02-19 Bavarian Nordic A/S Genes hotes du virus de la vaccine permettant d'augmenter le titre de l'avipoxvirus
CA2520637A1 (fr) 2003-03-28 2004-10-14 The Government Of The United States Of America, As Represented By The Se Cretary, Department Of Health And Human Services Mva exprimant des genes modifies enveloppe, gag et pol du vih
ES2539010T3 (es) 2004-08-27 2015-06-25 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Virus MVA recombinantes que expresan genes env, gag y pol modificados de VIH clado A/G, clado B, y clado C
AU2008250596C1 (en) 2007-05-14 2010-11-25 Bavarian Nordic A/S Purification of Vaccinia virus- and recombinant Vaccinia virus-based vaccines
US20120135032A1 (en) 2009-10-08 2012-05-31 Bavarian Nordic A/S Generation of a broad t-cell response in humans against hiv
NZ603620A (en) 2010-07-20 2015-01-30 Bavarian Nordic As Method for harvesting expression products
EP2620446A1 (fr) 2012-01-27 2013-07-31 Laboratorios Del Dr. Esteve, S.A. Immunogènes pour la vaccination contre le VIH
DE102013004595A1 (de) 2013-03-15 2014-09-18 Emergent Product Development Germany Gmbh RSV-Impfstoffe
PL3402802T3 (pl) 2016-01-08 2023-06-05 Geovax, Inc. Kompozycje i sposoby generowania odpowiedzi immunologicznej względem antygenu powiązanego z guzem nowotworowym
US11666651B2 (en) 2019-11-14 2023-06-06 Aelix Therapeutics, S.L. Prime/boost immunization regimen against HIV-1 utilizing a multiepitope T cell immunogen comprising Gag, Pol, Vif, and Nef epitopes
WO2021260065A1 (fr) 2020-06-24 2021-12-30 Consejo Superior De Investigaciones Científicas (Csic) Vaccin à base de mva contre la covid-19 exprimant des antigènes de sras-cov-2
EP3928789A1 (fr) 2020-06-24 2021-12-29 Consejo Superior de Investigaciones Científicas (CSIC) Vaccin à base de mva contre le covid-19 exprimant les antigènes du sars-cov-2
EP4108257A1 (fr) 2021-06-23 2022-12-28 Consejo Superior De Investigaciones Científicas Vaccin à base du virus de la vaccine ankara (mva) contre la covid-19 exprimant une protéine sars-cov-2 s stabilisée dans une préfusion
WO2022269003A1 (fr) 2021-06-23 2022-12-29 Consejo Superior De Investigaciones Cientificas Vaccin à base de mva exprimant une protéine s du sars-cov-2 stabilisée par préfusion

Also Published As

Publication number Publication date
DK137392C (da) 1978-09-18
DE2145477A1 (de) 1973-03-15
ES406590A1 (es) 1975-09-16
DE2145477B2 (de) 1976-04-01
DK137392B (da) 1978-02-27
CH568392A5 (fr) 1975-10-31
AT320149B (de) 1975-01-27

Similar Documents

Publication Publication Date Title
SE389206B (sv) Legesinstellningsanordning
BE787901A (fr) Vaccin antivariolique
IT973049B (it) Dispositivo di formatura
BR7201651D0 (pt) Unidade dentaria
BE786707A (fr) Preparation de mitraille
IT950664B (it) Procedimento radiogoniometrico
FI53686C (fi) Avtappningspip med luftpassage
SE398198B (sv) Farmaceutisk anordning
DK143912C (da) Doseringsapparat
DK132563C (da) Sprededybel
BE794307A (fr) Vaccin anti-caries
BE792261A (fr) Preparation capillaire
AT315658B (de) Spike
SE383083B (sv) Synkroniseringsanordning
BE790036A (fr) Ambulance
SE380972B (sv) Dentalenhet
IT966747B (it) Procedimento per preparare dinitroantrachinoni
BE754523A (fr) Vaccins
TR17350A (tr) 6-hidroksi-dihidro-urasillerin imaline mahsus usul
AT322091B (de) Impfgeraet
IT975399B (it) Dispositivo terapeutico
IE35729B1 (en) Vaccine preparation
FI56454B (fi) Foer tvaopunktsreglering avsedd stegregulator med kopplingssteg
BE767285A (fr) Adjuvants de detersion
IT956377B (it) Poltrona odontoiatrica